Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Roche Holding AG | 3.48% | $196.60M | CHF294.84B | 47.36% | 73 Outperform | |
| ASML Holding | 3.30% | $186.56M | $559.08B | 97.90% | 81 Outperform | |
| Nestlé SA | 2.16% | $122.08M | CHF198.29B | 13.22% | 71 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.89% | $106.71M | €265.40B | -23.92% | 78 Outperform | |
| Novartis | 1.61% | $90.98M | $312.45B | 52.75% | 80 Outperform | |
| Sony | 1.60% | $90.26M | ¥21.22T | -15.54% | 73 Outperform | |
| AstraZeneca | 1.59% | $89.93M | £240.98B | 31.92% | 80 Outperform | |
| SAFRAN SA | 1.31% | $73.93M | €142.86B | 37.88% | 67 Neutral | |
| GlaxoSmithKline | 1.25% | $70.45M | £91.50B | 53.84% | 77 Outperform | |
| BHP Group Ltd | 1.23% | $69.77M | AU$265.54B | 37.39% | 68 Neutral |